A carregar...

Weekly paclitaxel plus trastuzumab in metastatic breast cancer pretreated with anthracyclines-a phase II multipractice study

<p>Abstract</p> <p>Background</p> <p>The 3-weekly combination of trastuzumab and paclitaxel has been approved for the treatment of advanced breast cancer based on a large pivotal study. However, mono and combination chemotherapy trials suggest that weekly paclitaxel has...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: John Matthias, Hinke Axel, Stauch Martina, Wolf Heiner, Mohr Benno, Hindenburg Hans-Joachim, Papke Jens, Schlosser Joachim
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2012-05-01
Colecção:BMC Cancer
Acesso em linha:http://www.biomedcentral.com/1471-2407/12/165
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!